Here’s the thread:It seems it doesn't have its own page yet on s4ME.
It is a fact that valacyclovir helps CFS patients in studies.
The thing is @PageofME, there have been some placebo controlled studies. The anti-virals did not seem to be useful.wait for a study to dis/prove a theory.
Me too except it was a bit rubbish at the cold sores and did nothing for the ME either!The thing is @PageofME, there have been some placebo controlled studies. The anti-virals did not seem to be useful.
We could maybe discuss whether the dosage tested was suitable. Possibly the studies pre-date this forum, perhaps the threads discussing those trials are on Phoenix Rising. @PageofME, you could make threads for the trials if we don't already have them and we can check out how reliable they are.
I suspect that the trials with their null results contributed significantly to the dampened enthusiasm for anti-virals.
I'm sure I mentioned my own experience up thread, but just noting it again. I had trouble with endless cold sores after ME/CFS onset. I tried valacyclovir for maybe 18 months. It definitely was useful in stopping the cold sores. It did not seem to have any effect on the ME/CFS symptoms.
A couple of days ago I had a look at Iwasaki's paper on the features of Long Covid by an immune profiling because it is that paper that they found their rationale to go after the role of pathogens in LC and ME/CFS, especially herpes viruses.
Just for the record: I didn't say that there is objective proof that "acyclovir works against CFS". It's a quote out of the account of the doctor I chatted with a couple of years ago on a German forum and posted their ME/CFS treatment regime. It was also her/him who thought that the reason for that was that aciclovir fought EBV. To my knowledge aciclovir doesn't have good activity against EBV. I've heard people claim it has some and others it has none. I think it's safe to say that there's no drug with a good activity against EBV. I was therefore never very interested in EBV.The thing is @PageofME, there have been some placebo controlled studies. The anti-virals did not seem to be useful.
We could maybe discuss whether the dosage tested was suitable. Possibly the studies pre-date this forum, perhaps the threads discussing those trials are on Phoenix Rising. @PageofME, you could make threads for the trials if we don't already have them and we can check out how reliable they are.
I suspect that the trials with their null results contributed significantly to the dampened enthusiasm for anti-virals.
I'm sure I mentioned my own experience up thread, but just noting it again. I had trouble with endless cold sores after ME/CFS onset. I tried valacyclovir for maybe 18 months. It definitely was useful in stopping the cold sores. It did not seem to have any effect on the ME/CFS symptoms.
Are you referring to me?But it just seems more and more that everyone thinks their theory is the right one. That’s problematic.
I don't think that my theory is the right one. But I want to know why I and some other patients (see on Reddit) have said for decades that aciclovir is a game changer for them and suppresses flares fully.
The trouble for the rest of us is that people say that about all sorts of things including homeopathy
So based on those figures, more report improvement with homeopathy than with antivirals, and more report deterioration with antivirals than with homeopathy


I'll say it again because I feel misunderstood: As for now I am solely interested in aciclovir. And I think you can't say it's a typical antiviral.Speaking of which:
Here are the figures again (MEA survey 2010). I'm aware the particular antivirals being touted and taken now are different, but you had 25% of people taking the antivirals below saying that they improved with them, and 30% of people taking homeopathy saying they improved with it:
View attachment 32317
View attachment 32316
I have witnessed a decent number of mild and moderate patients online saying things like game changer, went back to work, doing sports again.
No it was a general statement in line with comments Ive made on other threads recently.Are you referring to me?
I don't think that my theory is the right one. But I want to know why I and some other patients (see on Reddit) have said for decades that aciclovir is a game changer for them and suppresses flares fully.
That's why I am interested in herpes research and very happy that there is this new found interest in herpes reactivation in Long Covid research. With technologies and theories (abortive reactivation) that weren't around 20 years ago.
I'm aware that your interest is in aciclovir.I'll say it again because I feel misunderstood: As for now I am solely interested in aciclovir. And I think you can't say it's a typical antiviral.
These numbers are interesting to me because roughly 30% is the same number that improved in both groups in the rituximab phase III, isn’t it? It’s also the number who supposedly improve during pregnancy. I’m starting to assume about 30% of ME patients are improving or fluctuating upward at any given time.The 25% who took antivirals and improved may well have described similar experiences to those currently being described by those who have taken aciclovir, but since a similar proportion of people improve with homeopathy, the 25%'s improvement is likely to have been for other reasons.
Yeah, it's a reasonable rule of thumb in my opinion. 10-20% deteriorating is also pretty standard.These numbers are interesting to me because roughly 30% is the same number that improved in both groups in the rituximab phase III, isn’t it? It’s also the number who supposedly improve during pregnancy. I’m starting to assume about 30% of ME patients are improving or fluctuating upward at any given time.
In total, 46 patients fulfilled the predefined criterion for overall response: 26 (35.1% [CI, 25.2% to 46.5%]) in the placebo group and 20 (26.0% [CI, 17.5% to 36.7%]) in the rituximab group.
I’m always improving or declining to some extent. I wouldn’t say I’m “the same” for a whole 3 months, certainly not a whole 6 months.These numbers are interesting to me because roughly 30% is the same number that improved in both groups in the rituximab phase III, isn’t it? It’s also the number who supposedly improve during pregnancy. I’m starting to assume about 30% of ME patients are improving or fluctuating upward at any given time.